Lack of association between eNOS gene polymorphisms and ischemic heart disease in the Spanish population

American Journal of Medical Genetics

Volumn 116, Issue 3, 2003, Pages 243-248

  Via, Marc ^a   López Alomar, Antonio ^a   Valveny, Neus ^a   González Pérez, Emilio ^a   Bao, Meritxell ^a   Esteban, Esther ^a   Pintó, Xavier ^b   Domingo, Enric ^c   Moral, Pedro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

eNOS; Ischemic heart disease; Lipid levels; Nitric oxide; Spanish populations; Transmission disequilibrium

Indexed keywords

AMINO ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AMINO ACID SUBSTITUTION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DNA POLYMORPHISM; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPAIN;

EID: 0037222070     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.10805     Document Type: Article

References (29)

1. Albright GL, Andreassi JL, Steiner SS. 1988. Interactive effects of type A personality and psychological and physical stressors on human cardiovascular functions. Int J Psychophysiol 6:315-326.
2. Balligand JL, Cannon PJ. 1997. Nitric oxide synthases and cardiac muscle. Arterioscler Thromb Vasc Biol 17:1846-1858.
3. Clayton D. 1999. A generalization of the transmission disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177.
4. Elbaz A, Poirier O, Moulin T, Chédru F, Cambien F, Amarenco P. 2000. Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. Stroke 31:1634-1639.
5. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. 2001. Acidic hydrolysis as a mechanism for the cleavage of the Glu298 → Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276:26674-26679.
6. Fichera LV, Andreassi JL. 1998. Stress and personality as factors in women's cardiovascular reactivity. Int J Psychophysiol 28:143-155.
7. Friedman M, Rosenman R. 1959. Association of a specific overt behaviour pattern with increases in blood cholesterol, in blood clotting time, incidence of arcus senilis and clinical artery disease. J Am Med Assoc 169:1286-1296.
8. Guzik TJ, Black E, West NEJ, McDonald D, Ratnatunga C, Pillai R, Channon KM. 2001. Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. Am J Med Genet 100:130-137.
9. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. 1999. A common variant of the endothelial nitric oxide synthase (Glu298 → Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515-1520.
10. Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK, Whitsett C, Rawlins P, Evatt BL. 1999. The relationships between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 116:880-886.
11. Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. 1998. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 81:83-86.
12. Livshits G, Vainder M, Graff E, Blettner M, Schettler G, Brunner D. 1997. Tel-Aviv-Heidelberg three generation offspring study: genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Biol 9:357-370.
13. Markus HS, Ruigrok Y, Ali N, Powell JF. 1998. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 29:1908-1911.
14. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamaka I, Takahashi N, Kaneshige T, Teraoke H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K. 1998. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3-8.
15. Nathan C, Xie Q. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
16. Norusis MJ. 1992. SPSS Advanced Statistics. Chicago: SPSS.
17. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A, Ruidavets JB, Arvelier D, Luc G, Tiret L, Soubrier F, Cambien F. 1999. Polymorphisms of the endothelial nitric oxide synthase gene-no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 29:284-290.
18. Qian HS, Neplioueva V, Shetty GA, Channon KM, George SE. 1999. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 99:2979-2982.
19. Rudic RD, Sessa WC. 1999. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet 64:673-677.
20. Schneider S, Roessli D, Excoffier L. 2000. Arlequin ver. 2000: A software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
21. Sham PC, Curtis D. 1995. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 59:323-336.
22. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Gen 52:506-516.
23. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. 2000. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 97:2832-2835.
24. Valveny N. 2000. Factors de risc genètics per a la Cardiopatia Isquèmica. Barcelona: Universitat de Barcelona. 348 p.
25. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. 1996. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2:41-45.
26. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DEL. 1997. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17:3147-3153.
27. Wang XL, Sim AS, Wang MX, Murrell GAC, Trudinger B, Wang J. 2000. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471:45-50.
28. Yoon Y, Song J, Hong SH, Kim JQ. 2000. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 46:1626-1630.
29. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. 2000. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405-413.